{"id":252,"date":"2013-07-03T02:36:09","date_gmt":"2013-07-03T02:36:09","guid":{"rendered":"https:\/\/jacksangelsfoundation.com\/?page_id=252"},"modified":"2019-05-08T04:55:22","modified_gmt":"2019-05-08T11:55:22","slug":"research","status":"publish","type":"page","link":"https:\/\/jacksangelsfoundation.com\/?page_id=252","title":{"rendered":"Research"},"content":{"rendered":"

\"BLUE1\"<\/a>Projects and Partners<\/h2>\n

\u00a0For the latest clinical trials for DIPG<\/a><\/em><\/p>\n

.<\/p>\n

Jack’s Angels remains committed to the DIPG Research Fund (est. 2013) at Children’s Hospital Los Angeles through local fundraising efforts, our local children’s research institution, and is working actively in 2019 in research advocacy at the state and federal level.\u00a0 Research partner Children’s Cancer Therapy Development Institute is featured monthly on Childhood Cancer Talk Radio<\/a>, where a project manager is interviewed and the parent-led foundation funding the research is featured.\u00a0 Jack’s Angels advocacy is geared toward raising awareness for DIPG, pediatric brain cancer, the leading cause of death in children with cancer, and the most successful research funding organizations for DIPG such as The Cure Starts Now<\/a> and the DIPG Collaborative.\"Logo\"<\/a><\/p>\n

Equally important is the work of the Michael Mosier Defeat DIPG Foundation in Bethesda, MD, and the ChadTough Foundation in Ann Arbor, MI:\"Michael\"\"<\/a>Here in California, UCSF, Stanford University,\u00a0and the Pacific Pediatric Neuro-Oncology Consortium are consistently making solid contributions to DIPG research and expanding in global collaboration.<\/p>\n

\"monje-lab-group-banner-inside\"<\/a>Dr. Michelle Monje<\/a> and her lab at Stanford University, with\u00a0the Lucile Packard Children’s Hospital, is unparalleled in it’s commitment, among singular laboratories, to DIPG research. For more information, visit:http:\/\/neurology.stanford.edu\/labs\/monjelab\/<\/p>\n

Dr. Adam Green<\/a> at the University of Colorado, Denver, directs an extensive laboratory devoted to DIPG research, and practices at Children’s Hospital Colorado.\u00a0 \u00a0He has been a conferring expert along with Dr. Monje for the national DIPG Awareness Resolution in US Congress.<\/p>\n

RESEARCH LISTINGS and Helpful Organizations:<\/h2>\n

\"cctdi1flask\"<\/a>Children’s Cancer Therapy Development Institute (CC-TDI):<\/strong> http:\/\/cc-tdi.org, a non-profit biotech company dedicated to bringing therapies to children with cancer from the most promising research. \u00a0CC-TDI is a collaboration between families, scientists, advocates, and children’s cancer organizations, located in Portland, OR, \u00a0Scientific Director Dr. Charles Keller<\/a><\/p>\n

PNOC<\/a>:\u00a0 Pacific Pediatric Neuro-Oncology Consortium<\/strong><\/p>\n

\"Home\"<\/strong>The Pacific Pediatric Neuro-Oncology Consortium (PNOC) is a network of 18 children\u2019s hospitals that conduct clinical trials of new therapies for children with brain tumors. Our goal is to improve outcomes by translating the latest findings in cancer biology into better treatments for these children.<\/p>\n